Literature DB >> 3534889

Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues.

M Ben-David, T Kadar, A V Schally.   

Abstract

A sensitive micromethod for the determination of free and total prolactin receptors in normal or malignant tissues has been developed. Positive and negative quality controls are incorporated in the procedure. Either whole tissue or the pellet fraction remaining from tissue that had undergone processing for estrogen receptors can be used. Crude microsomal and plasma membrane fractions obtained by homogenization and differential centrifugation are incubated with labeled prolactin in the presence or absence of increasing amounts of unlabeled hormone. The labeled ligand is prepared by a stoichiometric iodination procedure in which one atom of iodine-125 is incorporated into one molecule of the hormone, resulting in an intact labeled prolactin with a high specific activity of 170-186 muCi/micrograms (1 Ci = 37 GBq). Human prolactin labeled by this procedure has much greater specific binding capacity to various rat tissues than does iodinated rat prolactin. This technique permits an accurate measurement of prolactin receptors in as little as 50 micrograms of membrane protein. Highest levels of free and total prolactin receptors were found in the liver of 60-day-old female rats that served as a positive control. Liver of immature 21-day-old male rats, devoid of prolactin receptors, was used as a negative control. The amount of detectable free receptors was dependent on the level of circulating plasma prolactin. In 3-day postpartum lactating rats with high prolactin levels in plasma, all prolactin receptors in the mammary glands were found to be occupied, and no free receptors could be detected. When these receptors were desaturated from the endogenous prolactin by exposure to 3 M MgCl2, one class of receptors in a high quantity (1.75 nmol/mg of protein) and with a moderate affinity (Kd = 6.41 X 10(-9) M) was detected. A similar type of receptor was found in the mammary glands of rats at midpregnancy and of cycling adult female rats. In malignant rat mammary tissue, however, fewer receptors (27 pmol/mg of protein) but with a very high affinity (Kd = 6.8 X 10(-14) M) were detected. Normal ventral and dorsolateral rat prostate contained two classes of prolactin receptors (Kd = 3.46 X 10(-10) M and 1.93 X 10(-8) M). In the cancerous rat prostate, however, only one of these two classes of receptors was detected, and the number was smaller.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534889      PMCID: PMC386931          DOI: 10.1073/pnas.83.21.8375

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Prolactin binding to rat mammary tumor tissue.

Authors:  P A Kelly; C Bradley; R P Shiu; J Meites; H G Friesen
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

3.  Mammary tumor virus potentiation of endogenous prolactin effect on mammary gland differentiation.

Authors:  M Ben-David; W E Heston; D Rodbard
Journal:  J Natl Cancer Inst       Date:  1969-02       Impact factor: 13.506

4.  Human prolactin in plasma, amniotic fluid and pituitary: identity and characterization by criteria of electrophoresis and isoelectric focusing in polyacrylamide gel.

Authors:  M Ben-David; D Rodbard; R W Bates; W E Bridson; A Chrambach
Journal:  J Clin Endocrinol Metab       Date:  1973-05       Impact factor: 5.958

Review 5.  The comparative endocrinology of prolactin.

Authors:  H A Bern; C S Nicoll
Journal:  Recent Prog Horm Res       Date:  1968

6.  Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.

Authors:  E R DeSombre; G Kledzik; S Marshall; J Meites
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

7.  Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.

Authors:  R Z Cai; B Szoke; R Lu; D Fu; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.

Authors:  R D Smith; R Hilf; A E Senior
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

9.  Correlation between hormone binding and growth response of rat mammary tumor.

Authors:  I M Holdaway; H G Friesen
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

10.  Localization of prolactin binding in prostate and testis: The role of serum prolactin concentration on the testicular LH receptor.

Authors:  C Aragona; H G Bohnet; H G Friesen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-02
View more
  2 in total

1.  Prolactin and prolactin receptors are expressed and functioning in human prostate.

Authors:  M T Nevalainen; E M Valve; P M Ingleton; M Nurmi; P M Martikainen; P L Harkonen
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.

Authors:  T Kadar; T W Redding; M Ben-David; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.